Bleeding Disorders

MD IQ

Conference Coverage

Therapy can extend half-life of FVIII

GLASGOW—Preliminary data suggest an investigational therapy can extend the half-life of factor VIII (FVIII) in patients with severe hemophilia A...

Pages